Greg Bradley serves as Executive at Petros Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Greg Bradley has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 26, 2023 involved exercising options for 6,050 shares valued at $0.
Greg Bradley currently holds 8,314 shares of Petros Pharmaceuticals, Inc. (PTPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Greg Bradley has been a net neutral trader of PTPI stock. They have purchased $0 and sold $0 worth of shares.
Greg Bradley's most recent insider trade was on Apr 26, 2023, when they sold 6,050 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,264 |
| $N/A |
| Discretionary |